Gail D. Zeevalk

Glutathione and Parkinson's disease: Is this the elephant in the room?

Gail D. Zeevalk, Roozbeh Razmpour, Laura P. Bernard · Biomedicine & Pharmacotherapy · 2008 · 208 citations

Neurodegenerative Diseases, Parkinson Disease, Pharmacology +3

Treatment of mice with methamphetamine produces cell loss in the substantia nigra

Patricia K. Sonsalla, Nina Jochnowitz, Gail D. Zeevalk et al. · Brain Research · 1996 · 161 citations

Psychoactive Drug, Pharmacological Study, Substantia Nigra +6

Evidence that the Loss of the Voltage‐Dependent Mg²⁺ Block at the <i>N</i>‐Methyl‐D‐Aspartate Receptor Underlies Receptor Activation During Inhibition of Neuronal Metabolism

Gail D. Zeevalk, William J. Nicklas · Journal of Neurochemistry · 1992 · 137 citations

Synaptic Transmission, Neurotransmitter, Neurotransmission +22

Acute neurotoxic effects of mancozeb and maneb in mesencephalic neuronal cultures are associated with mitochondrial dysfunction

Lisa M. Domico, Gail D. Zeevalk, Laura P. Bernard et al. · NeuroToxicology · 2006 · 127 citations

Mitophagy, Mitochondrial Function, Mitochondrial Dysfunction +13

MK‐801 Fails to Protect Against the Dopaminergic Neuropathology Produced by Systemic 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine in Mice or Intranigral 1‐Methyl‐4‐Phenylpyridinium in Rats

Patricia K. Sonsalla, Gail D. Zeevalk, Lawrence Manzino et al. · Journal of Neurochemistry · 1992 · 121 citations